Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-087099
Filing Date
2023-11-14
Accepted
2023-11-14 17:19:57
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_aditxtinc.htm   iXBRL 10-Q 1163080
2 CERTIFICATION f10q0923ex31-1_aditxt.htm EX-31.1 13727
3 CERTIFICATION f10q0923ex31-2_aditxt.htm EX-31.2 14092
4 CERTIFICATION f10q0923ex32-1_aditxt.htm EX-32.1 8363
  Complete submission text file 0001213900-23-087099.txt   6457271

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adtx-20230930.xsd EX-101.SCH 67794
6 XBRL CALCULATION FILE adtx-20230930_cal.xml EX-101.CAL 34575
7 XBRL DEFINITION FILE adtx-20230930_def.xml EX-101.DEF 325159
8 XBRL LABEL FILE adtx-20230930_lab.xml EX-101.LAB 684259
9 XBRL PRESENTATION FILE adtx-20230930_pre.xml EX-101.PRE 341545
54 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_aditxtinc_htm.xml XML 666168
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39336 | Film No.: 231408018
SIC: 2834 Pharmaceutical Preparations